Universal Scientific Industrial Shanghai Co Ltd (601231) fair value: what the stock is really worth
As of Nov 5, 2026: fair value (intrinsic value) of Universal Scientific Industrial Shanghai Co Ltd stock ¥16.32, price ¥18.70, that is 12.7% below the price, quality 57 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Oct 31, 2026.
How to read this chart
60‑month range ¥9.31 – ¥48.42 · fair‑value band ¥11.42 – ¥21.22 · the ¥18.70 price screens above the ¥16.32 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 31, 2026.
Follow Universal Scientific Industrial Shanghai Co in your weekly email
Every Wednesday you see whether Universal Scientific Industrial Shanghai Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Universal Scientific Industrial (Shanghai) Co., Ltd. engages in the design, engineering development, raw material procurement, production, testing, logistics, and after-sales service of electronic products and equipment in Mainland China, the rest of the Asia Pacific, Europe, and internationally.
Show moreShow less
The company offers Wi-Fi modules and LPWA products; Wi-Fi AP solutions, such as enterprise and wall plate AP, small business AP, gateway, wireless controllers, and Wi-Fi dock ODM/OEM products; IoT and WWAN modules, and system on modules; rack and edge servers; desktop and workstation motherboards; subcards, smart NIC, and high-speed interconnection products; switches; storage and flash arrays; and solid-state drives.
It also provides timing control, source, main, key, and backbone boards, as well as LED light bars and driver boards; smart stylus, EMR sensor boards, home control panels, drones, and smart flower pots; true wireless stereo Bluetooth earbuds modules, optical heart rate modules, hybrid watch PCBA and modules, and wristbands; and rugged handheld devices.
In addition, the company offers hair removal products, breast pumps, and hearing aids; patient monitors and automated external defibrillators; ultrasounds, computed tomography, magnetic resonance imaging, and x-rays.
Further, it provides fixed and mobile POS; automotive parts and accessories, including powertrain, power modules, exterior LED lighting, vehicle body, driving safety, and chassis; and automotive information and communication products.
Additionally, the company engages in real estate development and management; product repair; and trade and investment activities. It serves the wireless communication, cloud and storage, industrial and medical, consumer app development, and car electronics markets.
The company was founded in 1976 and is headquartered in Shanghai, the People's Republic of China. Universal Scientific Industrial (Shanghai) Co., Ltd. operates as a subsidiary of USI Enterprise Limited.
Stock analysis
Universal Scientific Industrial Shanghai Co Ltd (601231) currently trades at ¥18.70, while our model-based Fair Value estimate is ¥16.32, 13% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ¥21.72 per share, and 9 of the 26 models we run sit above the ¥18.70 price.
Bear case: the Dividend Discount group reads lowest at ¥3.93, and 17 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ¥11.42 (bear) to ¥21.22 (bull), the price of ¥18.70 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Technology sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Universal Scientific Industrial Shanghai Co Ltd reported revenue of 59.2B CNY in FY2025 versus 55.3B CNY in FY2021, a compound +1.7%/yr. Reported net income was 1.9B CNY in FY2025, compounding −0.1%/yr from FY2021.
Key figures
Market cap 41.8B CNY (≈ $6.3B) Mid · P/E ratio 22.5 · P/S ratio 0.67 · EPS (TTM) ¥0.8300 · Dividend yield 2.3% · Net margin 3.4% · Return on equity 10.1% · Return on assets (EBIT) 6.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 61% below its 52-week high and 9% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −15% fair-value upside, at −13%, 601231 screens cheaper than that median.
Fair Value models
Bear¥11.42Fair Value ¥16.32Bull¥21.22
Price ¥18.70 · Downside -12.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.3397 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−2.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.4%
Start year 2020 (pandemic). Over 10 years: +8.1% a year
Revenue growth 17 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+3.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+0.7%
Dividend (yield on the price)2.3%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.0.7% vs 9.0%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 4%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+20.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+17.0%
Yearly sales growth analysts expect, extended to five years.
After inflation (China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about +18.4% a year for the price and +15.1% for the forecasts.
AI conclusion: Limited public signals point to modest or no durable moat and weak pricing power as the main weakness, while the focus on AI and edge solutions stands as the chief potential strength.
Main risk: Exposure to declining automotive and communications segments amid broader Chinese corporate earnings weakness would hit revenue diversification and overall demand.
USI's electronic manufacturing services business shows clear divergence, with cloud and storage revenue surging while automotive and communications segments decline amid market pressures. Broader weakness in Chinese corporate earnings adds uncertainty to the recovery path. Our models see it as overvalued. Will the focus on AI and edge solutions outweigh exposure to slower traditional areas?
Compare Universal Scientific Industrial Shanghai Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electronic Components · 652 stocks
Beats the industry median on 11/15 measures
Overall it ranks above its industry peers.
Valuation
Quality Score57 · Above median
Fair Value upside−12.7% · Above median
Profitability
Return on equity (12 months)10.1% · Above median
Return on assets4.6% · Above median
Net margin (12 months)3.4% · Below median
Operating margin (12 months)4.2% · Below median
Growth and dividend
Revenue growth (quarter YoY)19.0% · Above median
Dividend yield (12 months)2.3% · Above median
Balance sheet
Debt / equity0.11× · Above median
Valuation Multiplesvs Electronic Components median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Universal Scientific Industrial Shanghai Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/601231
Frequently asked questions
Is Universal Scientific Industrial Shanghai Co Ltd (601231) overvalued or undervalued?
As of Oct 31, 2026, our model estimates a fair value of ¥16.32 versus a price of ¥18.70, about 13% lower (overvalued).
What is the fair value of 601231?
Our model-based fair value for Universal Scientific Industrial Shanghai Co Ltd is ¥16.32 (as of Oct 31, 2026), built from audited fundamentals. The current price: ¥18.70.
What is the quality score of 601231?
Universal Scientific Industrial Shanghai Co Ltd has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Universal Scientific Industrial Shanghai Co Ltd (601231)?
Our model-based price target is the fair value of ¥16.32 (as of Oct 31, 2026) from 26 valuation models. Cautious scenario ¥11.42, optimistic scenario ¥21.22. It is a calculation from audited fundamentals, not an analyst target.
What is the Universal Scientific Industrial Shanghai Co Ltd stock forecast for 2026?
Our models put fair value at ¥16.32, about 13% lower versus a price of ¥18.70 (overvalued). Cautious scenario ¥11.42, optimistic scenario ¥21.22. The calculation is refreshed regularly with new filings.
What is the revenue of Universal Scientific Industrial Shanghai Co Ltd (601231)?
Universal Scientific Industrial Shanghai Co Ltd reported trailing-twelve-month revenue of about 62.4B CNY (latest available figure, as of Oct 31, 2026).
Does Universal Scientific Industrial Shanghai Co Ltd pay a dividend?
Universal Scientific Industrial Shanghai Co Ltd currently shows a dividend yield of 2.30% relative to its recent price (as of Oct 31, 2026).
What growth is priced into Universal Scientific Industrial Shanghai Co Ltd (601231)?
For today's price to be fair in a discounted-cash-flow model, Universal Scientific Industrial Shanghai Co Ltd would have to grow free cash flow by +20.4 % per year for five years (discount rate 10.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.4 % per year. As of Oct 31, 2026.
What discount rate (WACC) does the fair value of 601231 use?
Our models discount Universal Scientific Industrial Shanghai Co Ltd at 10.9 %: a base by market capitalisation (mid), damped by beta 1.17, country premium for China. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Universal Scientific Industrial Shanghai Co Ltd that is +20.4 % per year a year over ten years, using the same discount rate (10.9 %) and the same formula as our fair value.
How much growth has Universal Scientific Industrial Shanghai Co Ltd (601231) delivered so far?
Over the past 5 years revenue at Universal Scientific Industrial Shanghai Co Ltd grew +4.4 % a year. The price currently implies +20.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Universal Scientific Industrial Shanghai Co Ltd (601231) growing?
The median revenue growth in the sector is +11.3 % a year. That is the yardstick for the growth priced into Universal Scientific Industrial Shanghai Co Ltd (+20.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Universal Scientific Industrial Shanghai Co Ltd (601231)?
The free-cash-flow yield on the price is 2.66 % in the last fiscal year (free cash flow was negative over the last twelve months): that much free cash flow Universal Scientific Industrial Shanghai Co Ltd produces per unit of market value. When it exceeds the discount rate of our models (10.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Universal Scientific Industrial Shanghai Co Ltd (601231)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Universal Scientific Industrial Shanghai Co Ltd it is ¥16.32 per share (as of Oct 31, 2026), against a price of ¥18.70. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Universal Scientific Industrial Shanghai Co Ltd stock overvalued or undervalued in 2026?
As of Oct 31, 2026, 601231 trades above its calculated fair value: price ¥18.70, fair value ¥16.32, a gap of about −13% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 601231?
No. The price is what the market pays today (¥18.70); the fair value is what the company's own numbers justify (¥16.32). For Universal Scientific Industrial Shanghai Co Ltd the two are ¥2.38 per share apart. That gap is exactly why we show both numbers side by side.
How much is Universal Scientific Industrial Shanghai Co Ltd worth?
The market values Universal Scientific Industrial Shanghai Co Ltd at about 41.8B CNY (market capitalisation, as of Oct 31, 2026). Per share that is ¥18.70; our models calculate a fair value of ¥16.32 per share.
What do the bullish and bearish scenarios say about 601231?
Our models span a range for Universal Scientific Industrial Shanghai Co Ltd: cautious scenario ¥11.42, base ¥16.32, optimistic ¥21.22 per share (as of Oct 31, 2026, price ¥18.70). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 601231?
Universal Scientific Industrial Shanghai Co Ltd trades at a price-to-earnings ratio of 22.5 (as of Oct 31, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥16.32 is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 26.3 (reported for FY2025: 22.5). Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, FY2025 ex one-offs: 23.1. Other multiples: PEG 0.7, P/B 2.0, P/S 0.7, EV/EBITDA 9.4.
What is the PEG ratio of 601231?
The PEG ratio of Universal Scientific Industrial Shanghai Co Ltd is 0.70 (P/E divided by earnings growth, as of Oct 31, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Universal Scientific Industrial Shanghai Co Ltd (601231)?
Balance-sheet figures for Universal Scientific Industrial Shanghai Co Ltd (as of Oct 31, 2026): return on equity 10.1%, debt of 0.11 per unit of equity. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is 601231 from its 52-week high?
Universal Scientific Industrial Shanghai Co Ltd trades at ¥18.70, about 61% below its 52-week high of ¥48.42 and 9% above the low of ¥17.10 (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of ¥16.32 is for.
Which stocks are comparable to Universal Scientific Industrial Shanghai Co Ltd?
From the same area (Technology) we also value Amphenol Corporation, Hon Hai Precision Industry Co, Corning Incorporated, Delta Electronics, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Universal Scientific Industrial Shanghai Co Ltd stock attractive at the current price?
The data as of Oct 31, 2026: price ¥18.70, calculated fair value ¥16.32 (−13%), Quality Score 57/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 601231 calculated?
We run Universal Scientific Industrial Shanghai Co Ltd through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥16.32, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. Universal Scientific Industrial Shanghai Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Universal Scientific Industrial Shanghai Co Ltd (601231)?
The closing price on Nov 5, 2026 was ¥18.70. Our model-based fair value is ¥16.32, about 13% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Universal Scientific Industrial Shanghai Co Ltd right now?
Solid but not exceptional quality (57/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (¥11.42 to ¥21.22) leaves room in how you read the outcome.
Where does the earnings growth of Universal Scientific Industrial Shanghai Co Ltd (601231) come from?
Earnings per share at Universal Scientific Industrial Shanghai Co Ltd grew +9.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share +11.1 %, EBIT margin −1.4 %, tax rate +0.3 %, residual (interest, one-offs) −0.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Universal Scientific Industrial Shanghai Co Ltd
How large is the market capitalisation of Universal Scientific Industrial Shanghai Co Ltd (601231)?
The market capitalisation of Universal Scientific Industrial Shanghai Co Ltd is 41.8B CNY (≈ $6.3B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Universal Scientific Industrial Shanghai Co Ltd (601231)?
The price-to-sales ratio of Universal Scientific Industrial Shanghai Co Ltd is 0.67 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Universal Scientific Industrial Shanghai Co Ltd (601231)?
Earnings per share at Universal Scientific Industrial Shanghai Co Ltd are ¥0.8300 (price ÷ EPS = P/E 22.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Universal Scientific Industrial Shanghai Co Ltd (601231)?
The dividend yield of Universal Scientific Industrial Shanghai Co Ltd is 2.3% (payout 60.6%, on adjusted earnings, reported 51.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Universal Scientific Industrial Shanghai Co Ltd (601231)?
The net margin of Universal Scientific Industrial Shanghai Co Ltd is 3.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Universal Scientific Industrial Shanghai Co Ltd (601231)?
The return on equity (ROE) of Universal Scientific Industrial Shanghai Co Ltd is 10.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Universal Scientific Industrial Shanghai Co Ltd (601231)?
On an EBIT basis the return on assets of Universal Scientific Industrial Shanghai Co Ltd is 6.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Universal Scientific Industrial Shanghai Co Ltd (601231)?
The operating margin of Universal Scientific Industrial Shanghai Co Ltd is 4.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Universal Scientific Industrial Shanghai Co Ltd (601231)?
Revenue at Universal Scientific Industrial Shanghai Co Ltd is growing +19.0% versus a year earlier (3y avg −4.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Universal Scientific Industrial Shanghai Co Ltd (601231)?
Earnings per share at Universal Scientific Industrial Shanghai Co Ltd are growing +7.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Universal Scientific Industrial Shanghai Co Ltd (601231) hold?
Universal Scientific Industrial Shanghai Co Ltd holds more cash than debt, 7.7B CNY net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Universal Scientific Industrial Shanghai Co Ltd in the live analysis
One click puts Universal Scientific Industrial Shanghai Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Oct 31, 2026